Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Magazine

Table: What's in Store for J&J?


Possible targets for the health-care giant:

SCIOS

Its new drug for heart failure could bring in $500 million a year.

GILEAD SCIENCES

Its new HIV drug is off to a good start. Some analysts believe it could generate close to $1 billion in sales.

CEPHALON

Provigil, its fast-growing drug for narcolepsy, may eventually be used for a range of other sleep disorders--and garner $700 million in sales.

CV THERAPEUTICS

A drug in the works for angina could be worth $500 million a year.


LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus